Search

everythinglearnresearchcommunity

for

Search:↓

Women with polycystic ovary syndrome tend to have a longer anogenital distance.

Ginseng is possibly safe but its effectiveness is unclear due to poor quality studies and mixed results.

Tracnil™, a mix of myo-inositol, folic acid, and vitamin D3, safely reduced acne, improved excessive hair growth, and fixed irregular periods in overweight women with PCOS.

Scalp cooling can help prevent chemotherapy-induced hair loss with a 50-90% success rate and is safe for patients.

Post-finasteride Syndrome causes lasting negative effects, but more research is needed for treatment and risk evaluation.

FPHL common in Taiwanese women; risk factors include BMI, high glucose, early puberty, fewer childbirths, oral contraceptives, and UV exposure.

Finasteride use doesn't cause sexual dysfunction in men with hair loss.

Low-level laser therapy safely and effectively improves hair growth and coverage for male and female pattern hair loss.

Treatment with plasma rich in growth factors improved hair density and thickness for hair loss patients.

5-alpha reductase inhibitors slightly increase the risk of sexual and mood side effects, and breast growth in men.

Depression severity is not linked to PCOS markers like BMI, insulin resistance, or testosterone levels.

In 2009, there were new medical devices, treatments for gynecological conditions, updated health guidelines, and legal developments in women's health.

Hormone imbalances can cause skin diseases, and understanding these links is important for diagnosis and treatment.

Hair loss in Chinese college students leads to various psychological issues, so treatment should address both hair loss and mental health.

Men who start balding at age 20 may have a higher chance of getting aggressive prostate cancer.

Male and female skin differ due to hormones, affecting conditions like hair loss, acne, and skin cancer, and suggesting a need for gender-specific treatments.

Women with type 1 diabetes often have polycystic ovary syndrome and excess male hormones, which are frequently undiagnosed.

Minoxidil was more effective than laser therapy for hair loss, and the report also highlighted the need for more research on PRP for a different hair loss condition, the impact of social media on alopecia views, and a warning on turmeric causing nail discoloration.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

Platelet-Rich Plasma and stem cell therapy can increase hair count and density, but the best method for preparation and treatment still needs to be determined.

Low-dose flutamide improved hirsutism and satisfaction in women but had common side effects, causing some to stop treatment.

5α-reductase inhibitors can cause serious and possibly lasting sexual and psychological side effects.

Young Czech women with PCOS have a higher risk of heart problems and should be regularly checked for cholesterol and glucose issues.

Female pattern hair loss involves hormonal factors, genetics, and may be linked to low ferritin levels.

Testosterone therapy may slightly improve sexual function in postmenopausal women, but its long-term safety is unknown.

Insulin resistance is significantly linked to a higher risk of depression in women with PCOS.

The review concluded that male pattern baldness is mostly seen negatively, affecting attractiveness and social appeal.

Treat pattern hair loss with finasteride and topical minoxidil.

The guideline suggests using specific criteria to diagnose PCOS, recommends various treatments for its symptoms, and advises screening for related health issues.

Hormone treatments for transgender individuals generally improve mental health and physical transition, with some health risks that require medical supervision.